BioSymetrics
Huntington, New York, United States
BioSymetrics is an AI-powered drug discovery company with a mission to bring the clinic to the bench and back. BioSymetrics integrates clinical and experimental data, using its patent pending Contingent AITM, to effectively navigate human disease biology and advance precision medicine. The company partners with a diverse network of life science and health system partners on end-to-end drug discovery, from gene disease prioritization to mechanism of action to clinical trial and small molecule design. BioSymetrics is a remote-first company with people clusters in Boston and Toronto.
Company Info
- Founded
- 2016
- Website
- www.biosymetrics.com/
Categories
Disease Areas
Technologies
Only accessible to MedStartr community members.
Join nowWhat do you think of BioSymetrics?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.